DOI: 10.4244/EIJV8I8A136

Statement on matching language to the type of evidence used in describing outcomes data

The Editors of the HEART Group Journals*

There are many different types of studies that can be conducted to provide evidence for clinical and outcomes research including, but not limited to, retrospective observational analyses, case-control studies and randomised controlled trials (RCTs). Each of these analyses has strengths and limitations, but most importantly, they all result in different types of conclusions about an intervention.

As illustrated in a series of examples provided in a separate review1, inappropriate word choice to describe results can lead to scientific inaccuracy. Therefore, the editors of the HEART Group (representing the world’s cardiovascular journals) recommend that all investigators and editors carefully select language to “match” the type of study conducted, without overstating findings or drawing erroneous conclusions about causality when they cannot be established.

As an illustrative example, when reporting results from an observational study that shows fewer deaths in one arm than in another, one should use descriptive statements such as, “the intervention is associated with lower mortality,” rather than definitive statements such as, “the intervention reduces mortality.” Conversely, when reporting the results of a rigorously conducted RCT with complete follow-up, in which the only difference captured between the two groups was the intervention, it may be appropriate to use somewhat more declarative statements such as, “the intervention reduced risk.” Additional examples of language matched with corresponding study type are listed in the Table 1.

In conclusion, all manuscripts should be written and edited not only for scientific accuracy but also for appropriateness of language used in describing the level of evidence provided by the study.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 8 Number 8
Dec 28, 2012
Volume 8 Number 8
View full issue


Key metrics

Trending articles
318.1

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
116.75

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
108.3

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
91.6

Image – Interventional flashlight

10.4244/EIJ-D-22-00344 Aug 5, 2022
First dedicated transcatheter leaflet splitting device: the ShortCut device
Tchétché D et al
free
71.3

State-of-the-art

10.4244/EIJ-D-22-00627 Feb 6, 2023
Left atrial appendage occlusion
Holmes D et al
free
68.9

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
60.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
49.55

CLINICAL RESEARCH

10.4244/EIJ-D-17-00962 Apr 6, 2018
A new optical coherence tomography-based calcium scoring system to predict stent underexpansion
Fujino A et al
free
43.45

State-of-the-Art Review

10.4244/EIJ-D-21-00145 Sep 20, 2021
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
Beyar R et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved